Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 15, 2026
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
View original at finance.yahoo.comJohnson & Johnson reports Q2 2026 results, raises 2026 outlook 2026 Second-Quarter reported sales growth of 6.6% to $25.3 Billion with operational growth of 5.6%* and adjusted operational growth of 5.7%* 2026 Second-Quarter earnings per share (EPS) of $2.27 and adjusted EPS* of $2.90 Strong operational performance resu…
O que extraímos desta fonte
The claims Via News extracted from this document. We point to the source; we don't replace it.
Johnson & Johnson delivered strong second-quarter results, demonstrating the power of our innovation, the depth of our portfolio and the momentum in our pipeline as we advance transformative treatments that address the world's toughest health challenges. With raised guidance and quarterly sales surpassing $25 billion, we are on track to meet our 2026 target of more than $100 billion in annual revenue for the first time in our Company's 140-year history.
60% confidence
Data points we hold from this source
| Johnson & Johnson Services, Inc. · operational sales growth | 5.6 percent |
| Johnson & Johnson Services, Inc. · reported sales growth | 6.6 percent |
| Johnson & Johnson Services, Inc. · adjusted net earnings | 7081 USD |
| Johnson & Johnson Services, Inc. · eps | 2.29 USD |
| Johnson & Johnson Services, Inc. · adjusted eps | 2.90 USD |
| Johnson & Johnson Services, Inc. · free cash flow | 6214 USD |
| Johnson & Johnson Services, Inc. · revenue | 23743 USD |
| Johnson & Johnson Services, Inc. · adjusted operational sales growth | 5.7 percent |
| Johnson & Johnson Services, Inc. · net income | 5537 USD |